AstraZeneca Plc is spinning off a company to develop drugs for immune disorders with as much as $250 million from a group of investors.
from Bloomberg http://ift.tt/2t9g2zF
Subscribe to:
Post Comments (Atom)
It's time to revise Jeff Bezos' famous '2-pizza rule' for the AI era, Cursor field CTO says
Cursor's David Pan wrote that two pizzas — the amount advised by Jeff Bezos — may be too much food to fill a team in the AI era. Alexand...
-
Big Tech is emerging a winner in the new H-1B system, while early-stage startups could lose out. Matthias Balk/nirat/Getty/Getty Images ...
-
Student-loan borrowers said they're worried about higher payments without the SAVE plan. Aaron Hawkins/Getty Images/iStockphoto Tru...
-
Healthcare costs will change for Americans in 2026. Reza Estakhrian/Getty Images Health insurance costs are expected to rise for Americ...
No comments:
Post a Comment